Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics ... is committed to advancing phage therapy with drug development ...

This important study analyzes the effect of heat treatment on phage-bacterial interactions and convincingly shows that prior heat exposure alters the bacterial cell envelope, enhancing persistence and ...

Now, scientists at ETH Zurich, in collaboration with Balgrist University Hospital, have created a fast and promising new test ...

Bacteriophages could be used as an alternative therapy for treating multidrug-resistant bacterial infections in animals and humans. Bacteriophages, also known as phages, were discovered early in ...

A bacteriophage is a type of virus that infects bacteria. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. All bacteriophages ...